- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06321133
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
March 17, 2024 updated by: Ilari Kuitunen, Kuopio University Hospital
High Flow Nasal Cannula Weaning in Acute Bronchiolitis - an Open-label Randomized Controlled Trials
The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis.
This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased.
The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Acute bronchiolitis is the most common cause of hospitalization among infants in Finland, with its primary etiology being the RS- virus.
Acute bronchiolitis is defined in Finland as an infant's first respiratory distress before the age of 1.
There is no effective pharmacological treatment for acute bronchiolitis.
High-flow nasal cannula therapy has been shown in large randomized trials to reduce the risk of intensive care unit admission for children.
High-flow nasal cannulas are typically used at a flow rate of 2 liters per kilogram per minute.
Despite widespread use, there is insufficient evidence to determine whether high-flow therapy should be discontinued abruptly or gradually tapered.
Observational studies indicate that the majority of units opt for abrupt discontinuation.
Common criteria for discontinuation include weaning off supplemental oxygen and maintaining normal oxygenation on room air for 4-6 hours.
Gradual weaning has been shown in observational studies to prolong hospitalization compared to immediate cessation of therapy.
In a randomized controlled trial conducted in a pediatric intensive care unit, direct discontinuation shortened the duration of treatment by up to two days.
However, there have been no previous randomized trials conducted on bronchiolitis patients.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ilari Kuitunen, MD, PhD
- Phone Number: +358447174910
- Email: ilari.kuitunen@uef.fi
Study Locations
-
-
-
Joensuu, Finland
- Recruiting
- Siun Sote
-
Contact:
- Paula Widgren, MD, PhD
- Phone Number: 0045813 330 8285
- Email: paula.widgren@siunsote.fi
-
Jyväskylä, Finland
- Recruiting
- Central Finland Hospital District
-
Contact:
- Milla Pitkänen, MD
- Phone Number: 0035814 2691811
- Email: milla.pitkanen@hyvaks.fi
-
Kuopio, Finland
- Recruiting
- Kuopio University Hospital
-
Sub-Investigator:
- Katri Backman, MD, PhD
-
Contact:
- Marjo Renko, Professor
-
Contact:
- Ilari Kuitunen, MD, PhD
- Phone Number: +358447174910
- Email: ilari.kuitunen@uef.fi
-
Sub-Investigator:
- Miika Arvonen, MD, PhD
-
Mikkeli, Finland
- Recruiting
- Mikkeli Central Hospital
-
Contact:
- Nicole Weisshoff, MD
- Phone Number: 0035815 3511
- Email: nicole.weisshoff@etelasavonha.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Clinically diagnosed acute bronchiolitis
- High flow nasal cannula treatment has lasted for at least 12 hours
- Measured saturation 95 or more with room air
- High flow rate is maximum 2l/kg/min
- The treating doctors considers the infant suitable to be without high flow
Exclusion Criteria:
- Major congenital anomaly of lungs, hearts or diaphragm
- Bacterial pneumonia
- Parents do not give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate ending
High flow is ended immediately
|
High flow is immediately ended
|
Active Comparator: Weaning
High flow is ended by gradually reducing the flow rate
|
High flow is gradually weaned by reducing the flow rate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospitalization time from randomization
Time Frame: One week
|
Time in hours from the randomization to the time the family leaves hospital.
|
One week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment failures
Time Frame: One week
|
Need to restart the high flow therapy
|
One week
|
Readmission rate
Time Frame: Seven days from discharge
|
Need for readmission
|
Seven days from discharge
|
Overall hospitalization time
Time Frame: One week
|
The overall time, which includes the time interval prior to randomization
|
One week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 13, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
February 13, 2024
First Submitted That Met QC Criteria
March 17, 2024
First Posted (Actual)
March 20, 2024
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 17, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5402589
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Bronchiolitis
-
ameer asadullah gullKing Edward Medical UniversityRecruitingBronchiolitis | Bronchiolitis Acute | Bronchiolitis, Viral | Nasal Continuous Positive Airway Pressure | Bronchiolitis Acute ViralPakistan
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
Hospices Civils de LyonRecruiting
-
Groupe Hospitalier du HavreCompletedAcute Viral BronchiolitisFrance
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Centre de Recheche du Centre...WithdrawnAcute Viral Bronchiolitis.Canada
-
Pontificia Universidade Católica do Rio Grande...CompletedAcute Viral Bronchiolitis
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Baqiyatallah Medical Sciences UniversityCompletedBronchiolitis Obliterans | Acute Obliterating BronchiolitisIran, Islamic Republic of
Clinical Trials on High flow nasal cannula immediate ending
-
Aga Khan University Hospital, PakistanUnknownApneic Oxygenation
-
Hospital Clinic of BarcelonaUnknownPatient Population Submitted to ERCPSpain
-
Montefiore Medical CenterCompletedMorbid Obesity | Noninvasive Ventilation | Deep SedationUnited States
-
Samsung Medical CenterFisher and Paykel HealthcareNot yet recruitingAcute Respiratory FailureKorea, Republic of
-
Children's Hospital Los AngelesCompletedHigh Flow Nasal CannulaUnited States
-
American University of Beirut Medical CenterRecruitingHigh-flow Nasal Cannula | Intravenous SedationLebanon
-
Mount Sinai Hospital, CanadaPrincess Margaret Hospital, CanadaActive, not recruitingHypoxia | Hematologic Malignancy | Immunocompromised | Post Hematopoietic Stem Cell Transplant | Pulmonary InfiltratesCanada
-
Rush University Medical CenterHospital Civil de GuadalajaraRecruitingObesity, Morbid | Extubation FailureUnited States, Mexico
-
Assistance Publique - Hôpitaux de ParisCompleted